Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Cuker

Showing results (101-110 of 258) with videos related to

Pageof 26
Sort By:
Journal of Clinical Epidemiology|March 4, 2021
Certainty of evidence and intervention's benefits and harms are key determinants of guidelines' recommendationsBenjamin Djulbegovic, Iztok Hozo, Shelly-Anne Li, et al.
Annals of Internal Medicine|October 17, 2022
Apixaban Versus Rivaroxaban in Patients With Atrial Fibrillation and Valvular Heart Disease : A Population-Based StudyGhadeer K Dawwas, Adam Cuker, Geoffrey D Barnes, et al.
Pharmacotherapy|November 8, 2019
Timing of Initiation of Oral Anticoagulation after Acute Ischemic Stroke in Patients with Atrial FibrillationMaureen A Smythe, Dennis Parker, Candice L Garwood, et al.
Chest|September 18, 2016
Laboratory Assessment of the Anticoagulant Activity of Direct Oral Anticoagulants: A Systematic ReviewBethany T Samuelson, Adam Cuker, Deborah M Siegal, et al.
Journal of Thrombosis and Thrombolysis|April 4, 2018
Quality of direct oral anticoagulant prescribing in elderly patients with non-valvular atrial fibrillation: results from a large urban health systemShakira J Grant, Shawn Kothari, Phyllis A Gimotty, et al.
Journal of Thrombosis and Haemostasis : JTH|July 20, 2025
Splenectomy for immune thrombotic thrombocytopenic purpura: a systematic review and meta-analysisSaarang R Deshpande, Hemza Tarawneh, Jiayi Tong, et al.
The New England Journal of Medicine|November 6, 2009
Clinical problem-solving. A bloody mysteryAdam Cuker, Jean M Connors, Joel T Katz, et al.
American Journal of Hematology|February 11, 2022
Cost-effectiveness of second-line therapies in adults with chronic immune thrombocytopeniaGeorge Goshua, Pranay Sinha, Natalia Kunst, et al.
Ejhaem|May 19, 2023
Overuse of corticosteroids in patients with immune thrombocytopenia (ITP) between 2011 and 2017 in the United StatesAdam Cuker, Joseph Tkacz, Janna Manjelievskaia, et al.
Blood Advances|October 7, 2024
Adeno-associated virus-based gene therapy for hemophilia A and B: a systematic review and meta-analysisSaarang R Deshpande, Keerthy Joseph, Jiayi Tong, et al.
Pageof 26

Showing results (101-110 of 258) with videos related to

Sort By:
Pageof 26
Journal of Clinical Epidemiology|March 4, 2021
Certainty of evidence and intervention's benefits and harms are key determinants of guidelines' recommendationsBenjamin Djulbegovic, Iztok Hozo, Shelly-Anne Li, et al.
Annals of Internal Medicine|October 17, 2022
Apixaban Versus Rivaroxaban in Patients With Atrial Fibrillation and Valvular Heart Disease : A Population-Based StudyGhadeer K Dawwas, Adam Cuker, Geoffrey D Barnes, et al.
Pharmacotherapy|November 8, 2019
Timing of Initiation of Oral Anticoagulation after Acute Ischemic Stroke in Patients with Atrial FibrillationMaureen A Smythe, Dennis Parker, Candice L Garwood, et al.
Chest|September 18, 2016
Laboratory Assessment of the Anticoagulant Activity of Direct Oral Anticoagulants: A Systematic ReviewBethany T Samuelson, Adam Cuker, Deborah M Siegal, et al.
Journal of Thrombosis and Thrombolysis|April 4, 2018
Quality of direct oral anticoagulant prescribing in elderly patients with non-valvular atrial fibrillation: results from a large urban health systemShakira J Grant, Shawn Kothari, Phyllis A Gimotty, et al.
Journal of Thrombosis and Haemostasis : JTH|July 20, 2025
Splenectomy for immune thrombotic thrombocytopenic purpura: a systematic review and meta-analysisSaarang R Deshpande, Hemza Tarawneh, Jiayi Tong, et al.
The New England Journal of Medicine|November 6, 2009
Clinical problem-solving. A bloody mysteryAdam Cuker, Jean M Connors, Joel T Katz, et al.
American Journal of Hematology|February 11, 2022
Cost-effectiveness of second-line therapies in adults with chronic immune thrombocytopeniaGeorge Goshua, Pranay Sinha, Natalia Kunst, et al.
Ejhaem|May 19, 2023
Overuse of corticosteroids in patients with immune thrombocytopenia (ITP) between 2011 and 2017 in the United StatesAdam Cuker, Joseph Tkacz, Janna Manjelievskaia, et al.
Blood Advances|October 7, 2024
Adeno-associated virus-based gene therapy for hemophilia A and B: a systematic review and meta-analysisSaarang R Deshpande, Keerthy Joseph, Jiayi Tong, et al.
Pageof 26